Structural biology and chemistry of protein arginine methyltransferases

被引:63
|
作者
Schapira, Matthieu [1 ,2 ]
de Freitas, Renato Ferreira [1 ]
机构
[1] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada
[2] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada
基金
英国惠康基金;
关键词
CRYSTAL-STRUCTURE; POTENT; INSIGHTS; BINDING; DOT1L; METHYLATION; INHIBITION; COMPLEX; SITE;
D O I
10.1039/c4md00269e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein arginine methyltransferases (PRMTs), an emerging target class in drug discovery, can methylate histones and other substrates, and can be divided into three subgroups, based on the methylation pattern of the reaction product (monomethylation, symmetrical or asymmetrical dimethylation). Here, we review the growing body of structural information characterizing this protein family, including structures in complex with substrate-competitive and allosteric inhibitors. We outline structural differences between type I, II and III enzymes and propose a model underlying class-specificity. We analyze the structural plasticity and diversity of the substrate, cofactor and allosteric binding sites, and propose that the conformational dynamics of PRMTs can be exploited towards the discovery of allosteric inhibitors that would antagonize conformationally active states.
引用
收藏
页码:1779 / 1788
页数:10
相关论文
共 50 条
  • [41] Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies
    Sauter, Camille
    Simonet, John
    Guidez, Fabien
    Dumetier, Baptiste
    Pernon, Baptiste
    Callanan, Mary
    Bastie, Jean-Noel
    Aucagne, Romain
    Delva, Laurent
    CANCERS, 2022, 14 (21)
  • [42] Protein arginine methyltransferases: promising targets for cancer therapy
    Hwang, Jee Won
    Cho, Yena
    Bae, Gyu-Un
    Kim, Su-Nam
    Kim, Yong Kee
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2021, 53 (05): : 788 - 808
  • [43] ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY Personalized Medicine PREFACE
    Donev, Rossen
    ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 102: PERSONALIZED MEDICINE, 2016, 102 : XI - XIII
  • [44] The emergence of protein arginine methyltransferases in skeletal muscle and metabolic disease
    vanLieshout, Tiffany L.
    Ljubicic, Vladimir
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2019, 317 (06): : E1070 - E1080
  • [45] Protein arginine methyltransferases: Evolution and assessment of their pharmacological and therapeutic potential
    Krause, Christopher D.
    Yang, Zhi-Hong
    Kim, Young-Sun
    Lee, Jin-Hyung
    Cook, Jeffry R.
    Pestka, Sidney
    PHARMACOLOGY & THERAPEUTICS, 2007, 113 (01) : 50 - 87
  • [46] Protein arginine methyltransferases (PRMTs) and transcriptionally active chromatin domains
    Jahan, Sanzida
    Xu, Wayne
    Ilic, Aleksander
    Davie, James R.
    BIOCHEMISTRY AND CELL BIOLOGY, 2017, 95 (02) : 182 - 182
  • [47] Targeting protein arginine methyltransferases in breast cancer: Promising strategies
    Wei, Yuancheng
    Lyu, Xiaodan
    Wang, Jia
    Zhang, Liufeng
    Xu, Chenxi
    Yuan, Shengtao
    Sun, Li
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 992
  • [48] Functional interplay between protein arginine methyltransferases in Trypanosoma brucei
    Lott, Kaylen
    Zhu, Lu
    Fisk, John C.
    Tomasello, Danielle L.
    Read, Laurie K.
    MICROBIOLOGYOPEN, 2014, 3 (05): : 595 - 609
  • [49] Approaches to measuring the activities of protein arginine N-methyltransferases
    Lakowski, Ted M.
    Zurita-Lopez, Cecilia
    Clarke, Steven G.
    Frankel, Adam
    ANALYTICAL BIOCHEMISTRY, 2010, 397 (01) : 1 - 11
  • [50] Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease
    Zhang, Yan
    Wei, Shibo
    Jin, Eun-Ju
    Jo, Yunju
    Oh, Chang-Myung
    Bae, Gyu-Un
    Kang, Jong-Sun
    Ryu, Dongryeol
    DIABETES & METABOLISM JOURNAL, 2024, 48 (04) : 487 - 502